U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: over 10,000 records

Showing results for "risk".

  1. Aspirin for the Prevention of Cardiovascular Disease: Recommendation Statement (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q4J7tsThw_6nwfB-p-f5Hp
    March 01, 2009 - Thus, decisions about aspirin therapy should con- sider the overall risks for coronary heart disease … Women The net benefit of aspirin depends on the initial risks for stroke and gastrointestinal bleeding … Shared decision making should be encouraged with women for whom the potential benefits and risks for … The WHS reported benefit with aspirin use in stroke re- duction (relative risk [RR], 0.83 [95% CI, 0.69 … is sufficiently high for the benefits to outweigh the risks as- sociated with treatment (a 10-year risk

  2. Archived: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-december-2017
    December 12, 2017 - Including the posttrial phases, the WHI trial had up to 13 years of follow-up to assess how risks for … hormone therapy (relative risk [RR], 1.23 [95% CI, 1.00 to 1.52]) during a mean follow-up of 5 years … There were significant trends toward lower risks of these outcomes in younger women (50 to 59 years) … and higher risks in older women (70 to 79 years) randomized to estrogen alone relative to placebo. 13 … Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

  3. Screening for Coronary Heart Disease: Clinician Fact Sheet (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/cAs__BR8J4rgcZ4vQgfaTx
    April 01, 2009 - A patient’s 10-year risk for CHD is determined based on age, gender, and conventional CHD risk factors … A variety of electronic or on-line risk calculators that use risk scoring algorithms derived from the … The added value of novel risk factors (e.g., CRP, homocysteine) above and beyond conventional risk … careful discussion with the patient about the risks and benefits of screening. … y If so, consider screening for this patient but only after a discussion of the risks and benefits.

  4. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/39643/psn-pdf
    December 21, 2014 - A systematic quantitative assessment of risks associated with poor communication in surgical care. … A systematic quantitative assessment of risks associated with poor communication in surgical care. … https://psnet.ahrq.gov/issue/systematic-quantitative-assessment-risks-associated-poor-communication- … surgical-care This study used failure mode and effect analysis to identify safety risks in perioperative … https://psnet.ahrq.gov/issue/systematic-quantitative-assessment-risks-associated-poor-communication-surgical-care

  5. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
    December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

  6. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
    December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

  7. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
    December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

  8. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
    December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

  9. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
    December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

  10. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
    December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

  11. Table 1: Evidence for Having an ALARA Policy Specific to Imaging Children (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
    December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT

  12. Fallpxtool4B (doc file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/fallpxtoolkit/fallpxtool4b.docx
    January 29, 2013 - Environmental risks (e.g., hooked up to IV). … Educates patient/family about fall risk factors. … Environmental risks (e.g., hooked up to IV). … CNA Reports any new fall risks to nurse. Keeps environment around bed clutter free. … Reviews medications for fall risk.

  13. Fallpxtool4B (doc file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/fallpxtoolkit/fallpxtool4b.docx
    January 29, 2013 - Environmental risks (e.g., hooked up to IV). … Educates patient/family about fall risk factors. … Environmental risks (e.g., hooked up to IV). … CNA Reports any new fall risks to nurse. Keeps environment around bed clutter free. … Reviews medications for fall risk.

  14. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

  15. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

  16. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

  17. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

  18. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

  19. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

  20. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (15806)

ce.effectivehealthcare.ahrq.gov (8089)

www.ahrq.gov (6685)

www.qualitymeasures.ahrq.gov (4730)

effectivehealthcare-admin.ahrq.gov (3111)

www.talkingquality.ahrq.gov (3076)

www.cpsi.ahrq.gov (3049)

www.monahrq.ahrq.gov (3041)

www.innovations.ahrq.gov (3021)

www.healthcare411.ahrq.gov (3014)

effectivehealthcare.ahrq.gov (2816)

www.cahps.ahrq.gov (2601)

cahps.ahrq.gov (2591)

healthcare411.ahrq.gov (2584)

monahrq.ahrq.gov (2527)

www.uspreventiveservicestaskforce.org (2432)

talkingquality.ahrq.gov (2227)

patientregistry.ahrq.gov (2150)

ahrqpubs.ahrq.gov (2093)

digital.ahrq.gov (2092)

preventiveservices.ahrq.gov (1839)

teamstepps.ahrq.gov (1667)

pcmh.ahrq.gov (938)

pbrn.ahrq.gov (914)

hcup-us.ahrq.gov (807)

cmext.ahrq.gov (774)

srdr.ahrq.gov (597)

meps.ahrq.gov (511)

cds.ahrq.gov (194)

qualityindicators.ahrq.gov (187)

nhqrnet.ahrq.gov (76)

cdsic.ahrq.gov (63)

ecareplan.ahrq.gov (51)

srdrplus.ahrq.gov (46)

www.psoppc.org (43)

pso.ahrq.gov (22)

staging-meps.ahrq.gov (10)

datatools.ahrq.gov (7)

covid-acts.ahrq.gov (6)

info.ahrq.gov (5)

cma.ahrq.gov (1)

jamanetwork.com (1)